Search results
Results From The WOW.Com Content Network
The COVID-19 vaccination in Singapore is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country. Singapore has a very high vaccination rate, with more than 92% of its total population (and ...
Pfizer's vaccine reduced the risk of symptomatic infection by 80% in children between 6 months and 4 years of age. Moderna's vaccine had an efficacy of 37% in kids 2 to 5 years old, and 51% in ...
The Moderna COVID‑19 vaccine, sold under the brand name Spikevax, is a COVID-19 vaccine developed by the American company Moderna, the United States National Institute of Allergy and Infectious Diseases (NIAID), and the Biomedical Advanced Research and Development Authority (BARDA). Depending on the jurisdiction, it is authorized for use in ...
In addition, it was announced on 14 December 2020 that the Pfizer-BioNTech vaccine was approved for use in Singapore, with the first batch slated for around end of December 2020. On 3 February 2021, the Moderna vaccine was approved for use in Singapore, with the first batch slated to arrive around March 2021.
Those who have received the Sinovac vaccine locally as well as returning Singapore residents who have received a vaccine overseas different from the two under the national vaccination drive would ...
"It's OK to mix and match Moderna and Pfizer," Dr. Ralph Gonzales, associate dean for clinical innovation and chief innovation officer for UC San Francisco, said at a campus town hall last week.
The Pfizer–BioNTech COVID-19 vaccine, sold under the brand name Comirnaty, [2] [32] is an mRNA-based COVID-19 vaccine developed by the German biotechnology company BioNTech. For its development, BioNTech collaborated with the American company Pfizer to carry out clinical trials, logistics, and manufacturing. [44] [45] It is authorized for use ...
New, modified versions of Pfizer’s and Moderna’s existing COVID-19 vaccines received a green light from the Food and Drug Administration to be used as booster shots on Wednesday, Aug. 31.